CIBC World Market’s ARK Genomic Revolution ETF ARKG Stock Holding History

CIBC World Market’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,325	Closed	-$220K	–	1358
2024 Q4	$220K	Sell	9,325 -2,007	-18%	-$49.4K	﹤0.01%	1273
2024 Q3	$290K	Buy	+11,332	New	+$289K	﹤0.01%	1140
2022 Q3	–	Sell	-9,285	Closed	-$292K	–	1228
2022 Q2	$292K	Sell	9,285 -35,439	-79%	-$1.24M	﹤0.01%	1028
2022 Q1	$2.05M	Buy	44,724 +21,714	+94%	+$1.04M	0.01%	579
2021 Q4	$1.41M	Buy	23,010 +2,868	+14%	+$198K	﹤0.01%	696
2021 Q3	$1.5M	Buy	20,142 +242	+1%	+$20.3K	﹤0.01%	679
2021 Q2	$1.84M	Sell	19,900 -26,069	-57%	-$2.22M	0.01%	616
2021 Q1	$4.08M	Buy	45,969 +39,377	+597%	+$3.91M	0.01%	403
2020 Q4	$615K	Buy	+6,592	New	+$525K	﹤0.01%	893

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CIBC World Market's ARKG Position: Q1 2025 in Review

CIBC World Market sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 9,325 shares — an estimated $220K sold.

CIBC World Market first reported a position in ARKG in Q4 2020 and held it in 9 quarters. The position peaked at $4.08M in Q1 2021. 217 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

CIBC World Market reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
CIBC World Market sold 9,325 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $220K.
CIBC World Market first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 9 quarters.
CIBC World Market's ARK Genomic Revolution ETF position peaked at $4.08M in Q1 2021.
217 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on CIBC World Market's 13F filing for Q1 2025, filed 14 May 2025.